APA citiranje

Shafique, M., Ismail‐Khan, R., Extermann, M., Sullivan, D., Goodridge, D., Boulware, D., . . . Han, H. S. (2019). A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer. Oncologist.

Citação norma Chicago

Shafique, Michael, et al. "A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer." Oncologist 2019.

MLA citiranje

Shafique, Michael, et al. "A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer." Oncologist 2019.